Mechanism of free and conjugated neocarzinostatin activity: Studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate

Zeitschrift fur Naturforschung Section C - Journal of Biosciences

Volumn 52, Issue 3-4, 1997, Pages 245-254

  Schönlau, Frank ^c   Maibücher, Axel ^c   Köhnlein, Wolfgang ^a   Garnett, Martin C ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NONE

Author keywords

Chromophore Uptake; Neocarzinostatin Conjugate; Transferrin

Indexed keywords

EID: 1842291030     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-1997-3-417     Document Type: Article

References (25)

1. Edo K., Mizugaki M., Koide Y., Seto H., Furihata K., Otaka N. and Ishida N. (1985), The structure of neocarzinostatin chromophore possessing a novel bicyclo-[7,3,0]dodecadiyne system. Tetrahedron Lett. 26, 331-334.
2. Edo K., Sato H., Saito K., Akiyama Y., Kato M., Mizugaki M., Koide Y. and Ishida N. (1986), Instability of neocarzinostatin-chromophore. Chem. Pharm. Bull. 34, 4425-4428.
3. Gottschalk U. (1990), Immunochemical investigations for construction and characterisation of monoclonal antibody cytostatic conjugates. PhD thesis, Westfalian Wilhelms-University Münster, Germany.
4. Gottschalk U., Maibücher A., Menke H. and Köhnlein W. (1990), Estimation of neocarzinostatin activity in conjugates with monoclonal antibodies. J. Antibiotics 43, 1051-1054.
5. Gottschalk U., Garnett M. C. Ward R. K., Maibücher A. and Köhnlein W. (1991), Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies. J. Antibiotics 43, 1148-1154.
6. Jong G. de, van Dijk J. P. and van Eijk H. G. (1990), The biology of transferrin. Clin. Chim. Acta 190, 1-46.
7. Kappen L. S. and Goldberg I. H. (1980), Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells. Biochemistry 19, 4786-4790.
8. Kappen L. S., Napier M. A. and Goldberg I. H. (1980), Roles of chromophore and apoprotein in neocarzinostatin action. Proc. Natl. Acad. Sci. USA 1980 77, 1970-1974.
9. Klausner R. D., van Renswoude J., Ashwell G., Kempf C. Schechter A. N., Dean A. and Bridges K. R. (1983), Receptor-mediated endocytosis of transferrin in K562 cells. J. Biol. Chem. 258, 4715-4724.
10. Kohgo Y., Kondo H., Kato J., Sasaki K., Tsushima N., Nishisato T., Hirayama M., Fujikawa K., Shintani N., Mogi Y. and Niitsu Y. (1990), Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate in human leukemia cell line, K562. Jpn. J. Cancer Res. 81, 91-99.
11. 3H] propionate: Use in detecting and analyzing monoclonal antibodies. In: Methods of Enzymol. Vol 121 (Langone JJ. Vunakis H. van) Academic Press, Orlando Florida, p 670-678.
12. Lazarus H., Raso V. and Samy A. T. S. (1977), In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin. Cancer Res. 37, 3731-3736.
13. Lüders G., Köhnlein W., Sorg C. and Brüggen J. (1985), Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro. Cancer Immunol. Immunother. 20, 85-90.
14. Maeda H., Aikawa S. and Yamashita A. (1975), Subcellular fate of protein antibiotic neocarzinostatin in culture of a lymphoid cell line from Burkitt's lymphoma. Cancer Res. 35, 554-559.
15. Maibücher A., Schönlau F., Gottschalk U., Köhnlein W. and Garnett M. C. (1994), Neocarzinostatin immunoconjugates: in vitro evaluation of therapeutic potential. Pharmaceutical Science Communications 4, 253-261.
16. Myers A. G. and Proteau P. J. (1989), Evidence for spontaneous, low temperature biradical formation from a highly reactive neocarzinostatin chromophore-thiol conjugate. J. Am. Chem. Soc. 111, 1146-1147.
17. Myers A. G. (1987), Proposed structure of the neocarzinostatin chromophore-methylglycolat adduct; A mechanism for the nucleophilic activation of neocarzinostatin. Tetrahedron Letters 28, 4493-4496.
18. Napier M. A., Holmquist B., Strydom D. J. and Goldberg I. H. (1979), Neocarzinostatin: Spectral characterization and separation of a non-protein chromophore. Biochem. Biophys. Res Commun. 89, 635-642.
19. Napier M. A., Holmquist B. and Strydom D. J. (1981), Neocarzinostatin chromophore: Purification of the major active form and characterization of its spectral and biological properties. Biochemistry 20, 5602-5608.
20. Oda T. and Maeda H. (1987), Binding to and internalization by cultured cell of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer. Cancer Research 47, 3206-3211.
21. Oda T., Sato F. and Maeda H. (1987), Facilitated internalization of neocarzinostatin and its lipophilic copolymer conjugate, SMANCS, into cytosol in acidic pH. J. Natl. Cancer Inst. 79 No. 6, 1205-1210.
22. Roskams A. J. and Connor J. R. (1990), Aluminium access to the brain: A role for transferin and its receptor. Proc. Natl. Acad. Sci. USA 87, 9024-9027.
23. Schor N. F. (1989), Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture. J. Pharmacol. Exp. Therap. 249, 906-910.
24. Takahashi T., Yamaguchi T., Kitamura K., Suzuyama H., Honda M., Yokota T., Kotanagi H., Takahashi M., Hashimoto Y. (1988), Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer 61, 881-888.
25. Ward J. H., Kushner J. P. and Kaplan J. (1982), Regulation of HeLa cell transferrin receptors. J. Biol. Chem. 257, 10317-10323.